Cargando…
Effects of canagliflozin on weight loss in high-fat diet-induced obese mice
Canagliflozin, an inhibitor of sodium glucose co-transporter (SGLT) 2, has been shown to reduce body weight during the treatment of type 2 diabetes mellitus (T2DM). In this study, we sought to determine the role of canagliflozin in body weight loss and liver injury in obesity. C57BL/6J mice were fed...
Autores principales: | Ji, Wenjun, Zhao, Mei, Wang, Meng, Yan, Wenhui, Liu, Yuan, Ren, Shuting, Lu, Jun, Wang, Bing, Chen, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493335/ https://www.ncbi.nlm.nih.gov/pubmed/28665967 http://dx.doi.org/10.1371/journal.pone.0179960 |
Ejemplares similares
-
Protamine zinc insulin combined with sodium selenite improves glycometabolism in the diabetic KKAy mice
por: Lu, Juan, et al.
Publicado: (2016) -
Sex Differences in Metabolic Recuperation After Weight Loss in High Fat Diet-Induced Obese Mice
por: Guerra-Cantera, Santiago, et al.
Publicado: (2021) -
The potent synergistic effects of the combination of liraglutide and canagliflozin on glycemic control and weight loss
por: Bell, David S.H.
Publicado: (2014) -
A Novel Multiphase Modified Ketogenic Diet: An Effective and Safe Tool for Weight Loss in Chinese Obese Patients
por: Wu, Wenjun, et al.
Publicado: (2022) -
Liraglutide Exerts Antidiabetic Effect via PTP1B and PI3K/Akt2 Signaling Pathway in Skeletal Muscle of KKAy Mice
por: Ji, Wenjun, et al.
Publicado: (2014)